OM
Outset Medical, Inc.·Healthcare
4.39
0.227%(−0.01)
Close PriceLast Updated: — ET
52W L: $3.0052W H: $21.98
OM NEWS
globenewswire.com
6d ago
Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
SAN JOSE, Calif., May 21, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity (the “Company”), today announced that the Compensation Committee of its Board of Directors approved equity awards under the Company's Inducement Plan, as a material inducement to employment to two newly appointed non-executive employees, in each case, who were not previous employees or directors of the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4), which also requires a public announcement of any equity awards that are not made under a stockholder approved equity plan.
globenewswire.com
May 11
Outset Medical to Present at RBC Global Healthcare Conference
SAN JOSE, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today announced that members of management will participate at the RBC Capital Markets Global Health Care conference on Tuesday, May 19, 2026, at 10:30 a.m.
seekingalpha.com
May 9
Outset Medical, Inc. (OM) Q1 2026 Earnings Call Transcript
Outset Medical, Inc. (OM) Q1 2026 Earnings Call Transcript
marketbeat.com
May 8
Outset Medical Q1 Earnings Call Highlights
Outset Medical NASDAQ: OM reported first-quarter 2026 revenue of $27.9 million, as management pointed to “consistent execution” in console utilization, new customer additions, gross margin expansion, and cash discipline, while acknowledging that capital order timing weighed on results.
zacks.com
May 7
Outset Medical, Inc. (OM) Reports Q1 Loss, Lags Revenue Estimates
Outset Medical, Inc. (OM) came out with a quarterly loss of $0.83 per share versus the Zacks Consensus Estimate of a loss of $0.79. This compares to a loss of $3.24 per share a year ago.
globenewswire.com
May 7
Outset Medical Reports First-Quarter Results
SAN JOSE, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today reported financial results for the first quarter ended March 31, 2026.
